106 related articles for article (PubMed ID: 9678719)
1. Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia.
Fontenay-Roupie M; Dupont JM; Picard F; Fichelson S; Botella A; Melle J; Guesnu M; Casadevall N; Dreyfus F; Bouscary D
Leuk Res; 1998 Jun; 22(6):527-35. PubMed ID: 9678719
[TBL] [Abstract][Full Text] [Related]
2. The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia.
Adams JA; Liu Yin JA; Brereton ML; Briggs M; Burgess R; Hyde K
Br J Haematol; 1997 Oct; 99(1):139-46. PubMed ID: 9359514
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
4. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
[TBL] [Abstract][Full Text] [Related]
5. Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro.
Filippi MD; Porteu F; Le Pesteur F; Rameau P; Nogueira MM; Debili N; Vainchenker W; de Sauvage FJ; Kupperschmitt AD; Sainteny F
Exp Hematol; 2000 Dec; 28(12):1363-72. PubMed ID: 11146158
[TBL] [Abstract][Full Text] [Related]
6. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.
Xie X; Chan RJ; Johnson SA; Starr M; McCarthy J; Kapur R; Yoder MC
Blood; 2003 Feb; 101(4):1329-35. PubMed ID: 12393382
[TBL] [Abstract][Full Text] [Related]
8. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
[TBL] [Abstract][Full Text] [Related]
9. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia with absent radii: frequency of marrow megakaryocyte progenitors, proliferative characteristics, and megakaryocyte growth and development factor responsiveness.
al-Jefri AH; Dror Y; Bussel JB; Freedman MH
Pediatr Hematol Oncol; 2000 Jun; 17(4):299-306. PubMed ID: 10845228
[TBL] [Abstract][Full Text] [Related]
11. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
12. Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors.
Liu Yin JA; Adams JA; Brereton ML; Hann A; Harrison BD; Briggs M
Br J Haematol; 2000 Mar; 108(4):743-6. PubMed ID: 10792278
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation.
Molineux G; Hartley CA; McElroy P; McCrea C; McNiece IK
Blood; 1996 Aug; 88(4):1509-14. PubMed ID: 8695873
[TBL] [Abstract][Full Text] [Related]
14. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
15. Hierarchical structure of human megakaryocyte progenitor cells.
Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E
Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.
Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J
Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD
FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832
[TBL] [Abstract][Full Text] [Related]
20. Defective megakaryocytic development in myelodysplastic syndromes.
Hofmann WK; Kalina U; Koschmieder S; Seipelt G; Hoelzer D; Ottmann OG
Leuk Lymphoma; 2000 Jun; 38(1-2):13-9. PubMed ID: 10811444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]